BioSpace News Archive

Drug Development

Celltrion announces positive results for its cocktail therapy candidates including neutralisation data against Omicron variant

Celltrion Group announced results for its cocktail therapy candidates including neutralisation data against the Omicron variant.

January 3, 2022
·
6 min read
Biotech Beach

Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics

Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion of a $12 million Series A financing round.

January 3, 2022
·
4 min read
BioCapital

Emergent BioSolutions is to Participate in Investor Conferences

Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2022.

January 3, 2022
·
1 min read
Genetown

Apellis Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

Apellis Pharmaceuticals today announced that the company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022 at 8:15 a.m. ET.

January 3, 2022
·
1 min read
Biotech Beach

Recro to Present at H.C. Wainwright BioConnect 2022 Conference

Recro Pharma, Inc. today announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright BioConnect 2022 Conference.

January 3, 2022
·
1 min read
Policy

Applied Therapeutics Provides Regulatory Update on Galactosemia Program

Applied Therapeutics, Inc. today provided a regulatory update on the AT-007 Galactosemia program.

January 3, 2022
·
7 min read
Genetown

Curis to Present at H.C. Wainwright BioConnect Conference

Curis, Inc. today announced that James Dentzer, President and Chief Executive Officer of Curis, will present at the H.C. Wainwright BioConnect Conference.

January 3, 2022
·
1 min read
Business

Tennessee Oncology Appoints Dr. Stephen Schleicher as Chief Medical Officer and Promotes Dr. Natalie Dickson to President and Chief Strategy Officer

Tennessee Oncology, one of the largest providers of oncology care in the country, announced today that Stephen Schleicher , MD, MBA has been appointed Chief Medical Officer (CMO) effective January 1, 2022.

January 3, 2022
·
4 min read
Genetown

Alnylam to Webcast Presentation at 40th Annual J.P. Morgan Healthcare Conference

Alnylam to Webcast Presentation at 40th Annual J.P. Morgan Healthcare Conference.

January 3, 2022
·
2 min read
Drug Development

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Anebulo Pharmaceuticals, Inc. announces that the first patient has dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

January 3, 2022
·
4 min read